1-(1H-Benzimidazol-1-ylmethyl)-3-[2-(diisopropylamino)ethyl]-1H-benzimidazolium bromide 0.25-hydrate

dc.authoridDüşünceli, Serpil Demir/0000-0001-8765-4039
dc.authoridArslan, Hakan/0000-0003-0046-9442
dc.authoridÖzdemir, İsmail/0000-0001-6325-0216
dc.authoridCetinkaya, Bekir/0000-0002-4551-8650
dc.authorwosidDüşünceli, Serpil Demir/AAA-7160-2021
dc.authorwosidDemir, Serpil/AAI-1740-2019
dc.authorwosidArslan, Hakan/B-1081-2008
dc.authorwosidÖzdemir, İsmail/ABI-5192-2020
dc.contributor.authorArslan, Hakan
dc.contributor.authorVanDerveer, Don
dc.contributor.authorDemir, Serpil
dc.contributor.authorOzdemir, Ismail
dc.contributor.authorCetinkaya, Bekir
dc.date.accessioned2024-08-04T20:31:10Z
dc.date.available2024-08-04T20:31:10Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe title N-heterocyclic carbene derivative, C23H30N5+center dot Br-center dot 0.25H(2)O, was synthesized using microwave heating and was characterized by H-1 and C-13 NMR spectroscopy and a single-crystal X-ray diffraction study. The structure of the title compound are stabilized by a network of intra-and intermolecular C-H center dot center dot center dot Br hydrogen-bonding interactions. The crystal structure is further stabilized by pi-pi stacking interactions between benzene and imidazole fragment rings of parallel benzo[d] imidazole rings, with a separation of 3.486 (3) angstrom between the centroids of the benzene and imidazole rings. There is also an intermolecular C-H center dot center dot center dot pi interaction in the crystal structure. The C-N bond lengths for the central benzimidazole ring are shorter than the average single C-N bond, thus showing varying degrees of double-bond character and indicating partial electron delocalization within the C-N-C-N-C fragment. The isopropyl group is disordered over two sites with occupancies of 0.792 (10) and 0.208 (10).en_US
dc.description.sponsorshipInonu University Research Funden_US
dc.description.sponsorshipWe thank the Inonu University Research Fund (IU BAP: BAP: 2008/Gudumlu 3) for financial support.en_US
dc.identifier.doi10.1107/S160053680900765X
dc.identifier.endpageU1529en_US
dc.identifier.issn2056-9890
dc.identifier.pmid21582439en_US
dc.identifier.scopus2-s2.0-64149104124en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageO699en_US
dc.identifier.urihttps://doi.org/10.1107/S160053680900765X
dc.identifier.urihttps://hdl.handle.net/11616/94780
dc.identifier.volume65en_US
dc.identifier.wosWOS:000264798500133en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherInt Union Crystallographyen_US
dc.relation.ispartofActa Crystallographica Section E-Crystallographic Communicationsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectComplexesen_US
dc.title1-(1H-Benzimidazol-1-ylmethyl)-3-[2-(diisopropylamino)ethyl]-1H-benzimidazolium bromide 0.25-hydrateen_US
dc.typeArticleen_US

Dosyalar